Valebret Limited
01271125
Some Concerns
- Current liabilities exceed current assets (-10)
- 6 outstanding charges (-10)
Details
Compliance
Last accounts
31/08/2025
total exemption full
Next accounts due
31/05/2027
Confirmation statement
Last: 28/03/2026
Due 11/04/2027
Industry
Officers
director · Since 18/12/2012
PHARMACIST
BRITISH · UNITED KINGDOM · Age 50
Also on 7 other boards
director · Since 18/12/2012
PHARMACIST
BRITISH · ENGLAND · Age 47
Also on 25 other boards
director · Since 11/02/2013
DIRECTOR
BRITISH · UNITED KINGDOM · Age 38
Also on 1 other board
Persons with Significant Control
La Pharma Limited
83-85 Baker Street, London, W1U 6AG
Reg: 04995865 · Registrar Of Companies In England & Wales · Private Limited Company
Notified 06/04/2016
Charges6 outstanding
LLOYDS BANK PLC
LLOYDS BANK PLC
LLOYDS BANK PLC
LLOYDS BANK PLC
LLOYDS BANK PLC
SANTANDER UK PLC
CompanyRankvs 1081+ SIC 47730 peers63
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/08/2025
Net Worth
£1k
Balance sheet strength
Cash
£149k
Cash in the bank
Net Current Assets
£975k
Working capital
Current Assets
£1.5M
Current Liabilities
£532k
Fixed Assets
£124k
Debtors
£1.2M
Profit After Tax
-£5k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2025 | 2.83 |
| 2024 | 2.79 |
| 2023 | 2.51 |
Derived from filed accounts. Not audited figures.